Articles from AllerVie Health

AllerVie Health, a leading provider of allergy and immunology services in the United States, today announced the creation of the AllerVie Advisory Council (AAC) and the addition of Dr. Ruchi Gupta to its Board of Directors. The clinician-led council will provide critical insight, feedback, and accelerated decision-making on clinical practices, protocols, and operational projects. With Gupta’s world-renowned expertise in food allergy and asthma research, AllerVie’s leadership is positioned to drive innovation as the company continues to enhance patient care nationwide.

Today, AllerVie Health, a national network of allergy clinics, announces several key vice president promotions and a new hire to its executive team. These strategic leadership moves solidify AllerVie Health's position as a frontrunner in allergy and immunology, with a continued focus on delivering exceptional care.

Today, AllerVie Health, a national network of allergy clinics, announced that Rachel Russell will be the company's new chief experience officer (CXO). The advancement from chief marketing, integration, and technology officer to CXO reflects AllerVie's ongoing dedication to enhancing the patient experience and continuing its strategic leadership succession plans.

Today, AllerVie Health, a national network of allergy clinics, announced Tae Kim will be the company's new chief executive officer. The advancement from president to CEO reflects the company's strategic plan. Chris Roussos, executive chairman of the board and former chief executive officer, will continue in his role on AllerVie's board as executive chairman, where he remains actively engaged in key strategic activities on behalf of the company.

Today, AllerVie Health, a leading national provider of allergy and immunology services, announced the extensive optimization of its digital infrastructure within clinics across 12 states in 2023. The growth of patient care-centered technology includes the integration of an innovative pulmonary function testing solution, the implementation of a new electronic medical record (EMR) system, and improving quality of care with remote respiratory monitoring devices. Additionally, the company is seamlessly upgrading IT hardware and software to support these new technology solutions.

Today, AllerVie Health, a national network of board-certified allergists, announced its acquisition of Allergy & Asthma Associates of DuPage, expanding the network's reach to Chicago, Illinois. As part of this partnership, AllerVie Health welcomes Asya Segalene, MD, and her clinical team to its national platform of allergy health providers. In the coming months, the practice's two locations in Naperville and Downers Grove, Illinois, will fully transition to the AllerVie Health brand, adopting and rolling out a new digital patient experience.

AllerVie Health, a leading provider of allergy and immunology services in the United States, announces the addition of several new key management hires and corporate promotions. These strategic moves come as AllerVie continues its company-wide integration and optimization efforts, reflecting the company’s commitment to enhancing patient care and strengthening its position as a leading national healthcare provider.

Today, AllerVie Health, a leading provider of allergy and immunology services in the United States, announced that Southern Allergy & Asthma PC, originally acquired in 2021, will now fully transition to the AllerVie Health brand and their new technology infrastructure model.

AllerVie Health, a leading provider of allergy and immunology services in the United States, announced the consolidation of its clinic locations in The Villages, Florida, today as part of the strategic partnership with Allergy & Asthma Care of Florida and Allergy Sinus & Asthma Family Health Center. This consolidation will enable AllerVie to better serve its patients and increase scheduling availability, providing more service offerings over time.